Jefferies Expects Monsanto To Decline Bayer's Proposal

Loading...
Loading...

Monsanto Company MON confirmed an unsolicited offer from Bayer, without disclosing terms. Jefferies’ Laurence Alexander maintained a Hold rating for the company, with a price target of $95. The analyst believes the deal is “relatively unlikely” to go through, with a likelihood of less than 25 percent.

Analyst Laurence Alexander mentioned that even with the deal with Bayer [Rated: Hold] being unlikely, it could have a near-term positive impact on the shares of Monsanto, Novozymes [Rated: Hold] and FMC Corp FMC [Rated: Buy], while having a negative impact for BASF [Rated: Hold], Syngenta AG (ADR) SYT [Rated: Buy] and E I Du Pont De Nemours And Co DD [Rated: Hold].

Rejection Likely

“We expect Monsanto to object to the offer, given its conviction (more adamant than ours) in its R&D pipeline and longer-term competitive advantages,” Alexander wrote. He said that the current target of a mid-teens CAGR implied an EPS of ~$7.70 in 2019. On a 1.5x PEG ratio, this implied a stretch value of $169, or $127 in 2016, if discounted at 15 percent.

The prior targets would have supported an EPS of $10 and a stretch target of more than $250, implying more than $189 in 2016 on a 15 percent discount rate. “Rejection appears highly likely,” the analyst commented.

Loading...
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorReiterationAnalyst RatingsJefferiesLaurence Alexander
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...